Drug Cost Avoidance Resulting from Participation in Clinical Trials: A 10-Year Retrospective Analysis of Cancer Patients with Solid Tumors

The objective of this single-center retrospective study was to describe the clinical characteristics of adult patients with solid tumors enrolled in cancer clinical trials over a 10-year period (2010-2019) and to assess drug cost avoidance (DCA) associated with sponsors' contributions. The spon...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-04, Vol.16 (8), p.1529
Hauptverfasser:	Carreras, Maria-Josep, Renedo-Miró, Berta, Valdivia, Carolina, Tomás-Guillén, Elena, Farriols, Anna, Mañós, Laura, Vidal, Jana, Alcalde, María, De la Paz, Isabel, Jiménez-Lozano, Inés, Palacio-Lacambra, Maria-Eugenia, Sabaté, Nuria, Felip, Enriqueta, Garralda, Elena, Garau, Margarita, Gorgas, Maria-Queralt, Monterde, Josep, Tabernero, Josep
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic drugs Cancer Cancer therapies Clinical trials Corporate sponsorship Cost control Cytotoxicity Drugs Health care Health care expenditures Hospitals Immunotherapy Medical research Medical technology Oncology Patients Pharmaceutical industry Pharmacy Public health Solid tumors Standard of care Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!